Application Nr Approved Date Route Status External Links
NDA021346 None None None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Risperdal Consta ® Is An Atypical Antipsychotic Indicated: For The Treatment Of Schizophrenia. ( 1.1 ) As Monotherapy Or As Adjunctive Therapy To Lithium Or Valproate For The Maintenance Treatment Of Bipolar I Disorder. ( 1.2 ) 1.1 Schizophrenia Risperdal Consta ® (Risperidone) Is Indicated For The Treatment Of Schizophrenia [See Clinical Studies (14.1) ] . 1.2 Bipolar Disorder Risperdal Consta ® Is Indicated As Monotherapy Or As Adjunctive Therapy To Lithium Or Valproate For The Maintenance Treatment Of Bipolar I Disorder [See Clinical Studies (14.2 , 14.3) ] .

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Risperidone RISPERIDONE ZINC538312

Comments